Literature DB >> 6782654

Biliary concentrations of cefamandole and its use in biliary tract surgery.

J U Levi, A S Livingstone, O V Martinez, R Zeppa, T Malinin, D G Hutson, N C Einhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6782654

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN： 0300-8878


× No keyword cloud information.
  6 in total

1.  Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.

Authors:  J U Levi; O V Martinez; T I Malinin; R Zeppa; A Livingstone; D Hutson; P Calhoun
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

2.  Biliary excretion of moxalactam.

Authors:  O V Martinez; J U Levi; A Livingstone; T I Malinin; R Zeppa; D Hutson; N Einhorn
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

3.  Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery.

Authors:  P Cherrier; P Perrin; S Gueye; A M Bosio; P Tinel; P Blot; R Richer; F Fauvelle
Journal:  Pharm World Sci       Date:  1993-04-23

4.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

5.  Biliary and pancreatic excretion of cefamandole.

Authors:  G P Burns; T A Stein; M Cohen
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

6.  Concentrations of cefoxitin in gallbladder bile of cholecystectomy patients.

Authors:  J F Hansbrough; J E Clark
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.